Immunotherapy biotech BeneVir Biopharm raises $2 million
November 17, 2017 at 14:26 PM EST
The company is moving toward commercialization of its virus technology that can infect and kill cancer cells while evading the immune system.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.